Insider buying
~$54K3,000 sh @ $18.00
Traded Sep 27, 2024 · filed 164 days later
A Bioage Labs director paid $54K out of pocket for Bioage Labs shares. 3 other people at Bioage Labs bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 27, 2024 · Filed Mar 10, 2025
Bioage Labs's Principal Accounting Officer paid $47K out of pocket for Bioage Labs shares. 3 other people at Bioage Labs bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$47,376
Shares × reported transaction price
$25K–$100K
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
4 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
41 days before results of Nov 7, 2024
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.4% | +0.9% | −4.3% |
| 30 days | −22.1% | −5.6% | −16.4% |
| 90 days | −2.3% | +7.9% | −10.1% |
| 180 days | +15.7% | +16.7% | −1.0% |
| 365 days | +356.1% | +21.7% | +334.5% |
Past results only. Not a forecast.
Insider buying
Traded Sep 27, 2024 · filed 164 days later
A Bioage Labs director paid $54K out of pocket for Bioage Labs shares. 3 other people at Bioage Labs bought some too, in the same month.
Fund moves
3 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Fund moves
2 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.